These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma. Metz CH; Scheulen M; Bornfeld N; Lohmann D; Zeschnigk M Cancer Med; 2013 Apr; 2(2):208-15. PubMed ID: 23634288 [TBL] [Abstract][Full Text] [Related]
47. The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability. Li Y; He J; Qiu C; Shang Q; Qian G; Fan X; Ge S; Jia R J Cell Biochem; 2019 Apr; 120(4):5766-5776. PubMed ID: 30320917 [TBL] [Abstract][Full Text] [Related]
48. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778 [TBL] [Abstract][Full Text] [Related]
49. Driver mutations in García-Mulero S; Fornelino R; Punta M; Lise S; Varela M; Del Carpio LP; Moreno R; Costa-García M; Rieder D; Trajanoski Z; Gros A; Alemany R; Piulats JM; Sanz-Pamplona R Oncoimmunology; 2023; 12(1):2261278. PubMed ID: 38126027 [TBL] [Abstract][Full Text] [Related]
50. Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations. Solomon DA; Ramani B; Eiger-Moscovich M; Milman T; Uludag G; Crawford JB; Phan I; Char DH; Shields CL; Eagle RC; Bastian BC; Bloomer MM; Pekmezci M Ophthalmology; 2022 Dec; 129(12):1429-1439. PubMed ID: 35835335 [TBL] [Abstract][Full Text] [Related]
51. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool. Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620 [TBL] [Abstract][Full Text] [Related]
52. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141 [TBL] [Abstract][Full Text] [Related]
53. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases. Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561 [TBL] [Abstract][Full Text] [Related]
54. YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression. Li H; Li Q; Dang K; Ma S; Cotton JL; Yang S; Zhu LJ; Deng AC; Ip YT; Johnson RL; Wu X; Punzo C; Mao J Cell Rep; 2019 Dec; 29(10):3200-3211.e4. PubMed ID: 31801083 [TBL] [Abstract][Full Text] [Related]
55. Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism. de Lange MJ; Razzaq L; Versluis M; Verlinde S; Dogrusöz M; Böhringer S; Marinkovic M; Luyten GP; de Keizer RJ; de Gruijl FR; Jager MJ; van der Velden PA PLoS One; 2015; 10(9):e0138002. PubMed ID: 26368812 [TBL] [Abstract][Full Text] [Related]
56. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma. Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239 [TBL] [Abstract][Full Text] [Related]